A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

This exploratory trial was conducted to test the effects of an alpha7 nicotinic receptor partial agonist, TC-5619, on cognitive dysfunction and negative symptoms in subjects with schizophrenia. In the United States and India, 185 outpatients (18–60 years; male 69% 46% tobacco users) with schizophren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lieberman, Jeffrey A, Dunbar, Geoffrey, Segreti, Anthony C, Girgis, Ragy R, Seoane, Frances, Beaver, Jessica S, Duan, Naihua, Hosford, David A
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629385/
https://ncbi.nlm.nih.gov/pubmed/23303043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2012.259
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares